Jagsonpal Pharmaceuticals: The financial results for the period ended September 30, 2026
Jagsonpal Pharmaceuticals (JAGSNPHARM) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹1,469 crore.
What happened
Jagsonpal Pharmaceuticals (JAGSNPHARM) filed a disclosure with the exchanges on 28 October 2026 at 06:13 PM titled "The financial results for the period ended September 30, 2026".
Company snapshot
Jagsonpal Pharmaceuticals is a small-cap company, with a market value of about ₹1,469 crore.
The stock last traded at ₹223.1, against a 52-week range of ₹155–₹264.5 (15.7% below the high).
Before this filing the shares had moved −1.1% over the month and −2.9% over three months. Average daily turnover over the last 20 sessions was about ₹3.19 crore.
Promoters held 69.05% at the end of Q1 FY27, down 0.31% points from the previous quarter. Foreign institutions owned 2.30% and domestic institutions 0.62%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 76 | 10.8 | 1.6 |
| Q2 FY26 | 74 | 12.6 | 1.88 |
| Q3 FY26 | 73 | 11 | 1.67 |
| Q4 FY26 | 64 | 8.8 | 1.25 |
| Q1 FY27 | 82 | 13.2 | 2 |
What history shows
BCEIE's records show 3 previous results filings from the company since May 2026.
After those filings, the stock gained 0.1% on average the next trading day and was up 3.3% on average after five days (2 filings with price data).
Market-wide, 9,800 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 29 Jul 2026 | Unaudited Results For The Quarter Ended June 30, 2026 | +0.1% | +3.3% |
| 29 Jul 2026 | Board Meeting Outcome for Outcome Of Board Meeting Held On July 29,… | +0.1% | +3.3% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 28 October 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.